TickerFacts.

NewGenIvf Group Ltd (NIVF): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

-$10.54M
Year ended 2025-12-31
$499.2K2021-12-31: $365.5K2022-12-31: $499.2K2023-12-31: $73.4K2024-12-31: -$1.14M2025-12-31: -$10.54M-$10.54M
2021-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31-$10.54Mn/m2026-03-31, From 2025-01-01
2024-12-31-$1.14Mn/m2026-03-31, From 2024-01-01
2023-12-31$73.4K-85.3%2026-03-31, From 2023-01-01
2022-12-31$499.2K+36.6%2025-05-15, From 2022-01-01
2021-12-31$365.5Kn/a2024-08-20, From 2021-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Services-Misc Health & Allied Services, NEC), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
NewGenIvf Group Ltd (NIVF)2025-12-31-$10.54Mn/m
Cryo Cell International Inc (CCEL)2025-11-30$1.23M-68.9%
Mangoceuticals, Inc. (MGRX)2024-12-31-$7.96Mn/m
Pacific Health Care Organization Inc (PFHO)2025-12-31$1.03M+15.6%
Marpai, Inc. (MRAI)2025-12-31-$13.17Mn/m
Viemed Healthcare, Inc. (VMD)2025-12-31$51.56M+19.2%
BioRestorative Therapies, Inc. (BRTX)2025-12-31-$15.44Mn/m
Progyny, Inc. (PGNY)2025-12-31$90.22M+27.7%
agilon health, inc. (AGL)2025-12-31-$434.64Mn/m

Compare NIVF, CCEL, MGRX, PFHO side by side · Screen every company in Services-Misc Health & Allied Services, NEC ↗